Related Experiment Video
Updated: Jun 18, 2026

06:48
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
Published on: July 25, 2014
[The debate on preemptive transplantation: queries and limits].
1SSD Trapianti Rene e Pancreas, Azienda Ospedale, Universita' degli Studi, Padova, Italy. paolo.rigotti@unipd.it
Summary
Preemptive kidney transplantation improves patient outcomes and quality of life. However, including predialysis patients on Italian waiting lists raises concerns about equitable organ allocation and access to timely transplants.
Area of Science:
- Nephrology
- Transplantation Medicine
- Public Health Policy
Background:
- Preemptive kidney transplantation, performed before dialysis initiation, offers significant clinical and quality-of-life benefits over postdialysis transplants.
- In Italy, the inclusion of predialysis patients on kidney transplant waiting lists is a subject of ongoing debate.
- An estimated 20,000 predialysis patients could be eligible for preemptive kidney transplants in Italy.
Discussion:
- The current Italian waiting list exceeds 7,000 dialysis patients, with average wait times surpassing three years.
- The number of new dialysis patients admitted to the waiting list is higher than the number of transplants performed annually.
- Implementing a preemptive kidney transplant program using cadaver donors necessitates addressing critical organ allocation equity issues.
Key Insights:
- Preemptive transplantation is clinically superior and enhances patient well-being.
- Significant potential exists for increasing preemptive transplant candidates in Italy.
- Current system limitations and organ allocation policies pose challenges to equitable access.
Outlook:
- Further debate and policy development are required to integrate predialysis patients into the transplant waiting list.
- Addressing organ allocation equity is paramount for a successful preemptive transplant program.
- Optimizing transplant candidate selection and organ distribution is crucial for improving outcomes in kidney failure patients.
Related Concept Videos
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cell-mediated Immune Responses
Overview

